Oxford, UK-based #OMassTherapeutics' ambition to join the 'big biotech' ranks has been bolstered by an impressive £230 million ($310 million) third-round #financing.
@pharmaphorum.bsky.social@pharmaphorum.bsky.social
@pharmaphorum.bsky.socialOxford, UK-based #OMassTherapeutics' ambition to join the 'big biotech' ranks has been bolstered by an impressive £230 million ($310 million) third-round #financing.